iBio

$1.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-4.86%) Today

+$0.05 (+2.84%) As of 10:36 AM UTC after-hours

Why Robinhood?

You can buy or sell iBio and other stocks, options, and ETFs commission-free!

About IBIO

iBio, Inc., also called iBio, is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX. The listed name for IBIO is iBio, Inc.

CEO

Thomas F. Isett

Employees

Headquarters

New York, New York

Founded

1993

Market Cap

415.11M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

15.28M

High Today

$1.89

Low Today

$1.77

Open Price

$1.81

Volume

6.12M

52 Week High

$7.45

52 Week Low

$0.50

IBIO Earnings

-$0.04

-$0.03

-$0.01

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

-$0.04 per share

Actual

-$0.04 per share

Replay Earnings Call